ANIP Trading Below CEO's Recent Buy Price
November 17, 2015 at 10:24 AM EST
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on November 12, ANI Pharmaceuticals, Inc.'s CEO, Arthur Przybyl, invested $102,375.00 into 2,500 shares of ANIP, for a cost per share of $40.95..